← back to search

Giuseppe Caramanno

University of Padua · IT
Area of research
Surgery · Radiology, Nuclear Medicine and Imaging
Research interest
Research focused on Percutaneous coronary intervention and Myocardial infarction, with related work in Bioresorbable scaffold, Clinical endpoint, Target lesion. Notable publications include 'Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre...', 'Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective', and 'Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development...'.
h-index
citations
916
works
13
NIH funding
primary concept
email

Recent publications

A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study
EuroIntervention 2023cited by 22position: middledoi
Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper
International Journal of Cardiology 2022cited by 20position: middledoi
TCT-704 Feasibility of overlapped Magnesium-made bioresorbable scaffold implantation in long lesions: results from the multicenter italian registry (MAGIC)
Journal of the American College of Cardiology 2018cited by 0position: middledoi
TCT-353 Acute and mid-term performance of Magmaris Bioresorbable Scaffold implantation in complex lesions: a multicenter experience.
Journal of the American College of Cardiology 2018cited by 0position: middledoi
Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score
EuroIntervention 2017cited by 136position: middledoi
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions
JACC: Cardiovascular Interventions 2017cited by 16position: middledoi
Twelve-month outcomes after bioresorbable vascular scaffold implantation in patients with acute coronary syndromes. Data from the European Multicenter GHOST-EU Extended Registry
EuroIntervention 2017cited by 10position: middledoi
Early and midterm outcomes of bioresorbable vascular scaffolds for ostial coronary lesions: insights from the GHOST-EU registry
EuroIntervention 2016cited by 37position: middledoi
Bioresorbable vascular scaffold use for coronary bifurcation lesions: A substudy from GHOST EU registry
Catheterization and Cardiovascular Interventions 2016cited by 30position: middledoi
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents
JACC: Cardiovascular Interventions 2016cited by 25position: middledoi
Impact of overlapping on 1‐year clinical outcomes in patients undergoing everolimus‐eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST‐EU registry
Catheterization and Cardiovascular Interventions 2016cited by 14position: middledoi
Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry
EuroIntervention 2015cited by 451position: middledoi
Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective
EuroIntervention 2015cited by 155position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 10 papers (2015–2018) · 8 papers (2015–2017)Davide Capodanno · University of Catania8 papers (2015–2017)Tommaso Gori · Johannes Gutenberg University Mainz8 papers (2015–2017)Thomas Münzel · Medical Genetics Center8 papers (2015–2017)Alessio Mattesini · National University of Singapore8 papers (2015–2017)Piera Capranzano · Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele8 papers (2015–2017)Antonio Colombo · Fujita Health University8 papers (2015–2017)Carlo Di Mario · University of Almería8 papers (2015–2017)Azeem Latib · University of Edinburgh8 papers (2015–2017)Holger Nef · Agaplesion Diakonieklinikum Rotenburg8 papers (2015–2017)Corrado Tamburino · Istituti di Ricovero e Cura a Carattere Scientifico8 papers (2015–2017)Jens Wiebe · München Klinik8 papers (2015–2017)Maciej Lesiak · Witelon State University of Applied Sciences in Legnica8 papers (2015–2017)Christoph Naber · West German Heart and Vascular Center Essen7 papers (2015–2017)Julinda Mehilli · LMU Klinikum7 papers (2015–2017)Manel Sabaté · Hospital Clínic de Barcelona6 papers (2016–2017)Salvatore Brugaletta · Twitter (United States)6 papers (2016–2017) · 4 papers (2015–2017) · 2 papers (2016–2017)